MCM
IBB icon

Maryland Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Maryland Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.48M Hold
12,631
– – 0.12% 81
2022
Q2 		$1.49M Sell
12,631
-257
-2% -$30.5K 0.12% 85
2022
Q1 		$1.68M Buy
12,888
+73
+0.6% +$9.51K 0.11% 95
2021
Q4 		$1.96M Sell
12,815
-350
-3% -$54.2K 0.11% 88
2021
Q3 		$2.13M Hold
13,165
– – 0.13% 82
2021
Q2 		$2.15M Hold
13,165
– – 0.13% 80
2021
Q1 		$1.98M Sell
13,165
-1,710
-11% -$272K 0.13% 78
2020
Q4 		$2.25M Sell
14,875
-100
-0.7% -$14.3K 0.16% 74
2020
Q3 		$2.03M Hold
14,975
– – 0.17% 72
2020
Q2 		$2.05M Buy
14,975
+1,450
+11% +$185K 0.19% 71
2020
Q1 		$1.46M Buy
13,525
+11,320
+513% +$1.3M 0.17% 79
2019
Q4 		$266K Hold
2,205
– – 0.03% 157
2019
Q3 		$219K Hold
2,205
– – 0.03% 182
2019
Q2 		$241K Hold
2,205
– – 0.03% 169
2019
Q1 		$247K Hold
2,205
– – 0.03% 160
2018
Q4 		$213K Hold
2,205
– – 0.03% 160
2018
Q3 		$269K Hold
2,205
– – 0.04% 148
2018
Q2 		$242K Hold
2,205
– – 0.03% 147
2018
Q1 		$235K Hold
2,205
– – 0.03% 151
2017
Q4 		$235K Hold
2,205
– – 0.03% 154
2017
Q3 		$245K Hold
2,205
– – 0.04% 148
2017
Q2 		$228K Hold
2,205
– – 0.03% 155
2017
Q1 		$216K Buy
+2,205
New +$211K 0.03% 159
2016
Q4 		– Sell
-2,100
Closed -$203K – 172
2016
Q3 		$203K Buy
+2,100
New +$200K 0.03% 150
2016
Q1 		– Sell
-2,400
Closed -$271K – 164
2015
Q4 		$271K Hold
2,400
– – 0.04% 133
2015
Q3 		$243K Sell
2,400
-381
-14% -$45.7K 0.04% 144
2015
Q2 		$342K Sell
2,781
-390
-12% -$46.7K 0.05% 129
2015
Q1 		$363K Buy
3,171
+390
+14% +$43K 0.06% 126
2014
Q4 		$281K Hold
2,781
– – 0.05% 150
2014
Q3 		$254K Hold
2,781
– – 0.04% 159
2014
Q2 		$238K Buy
+2,781
New +$219K 0.04% 161

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Maryland Capital Management's IBB Position: Q3 2022 in Review

Maryland Capital Management held its iShares Biotechnology ETF (IBB) position steady in Q3 2022 at 12,631 shares worth $1.48M. The position accounts for 0.12% of the portfolio, ranked #81.

Maryland Capital Management first reported a position in IBB in Q2 2014 and has held it in 31 quarters since. The position peaked at $2.25M in Q4 2020. 830 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

  • Maryland Capital Management held 12,631 shares of iShares Biotechnology ETF worth $1.48M as of Q3 2022.
  • Maryland Capital Management left its iShares Biotechnology ETF share count unchanged in Q3 2022.
  • iShares Biotechnology ETF made up 0.12% of Maryland Capital Management's portfolio in Q3 2022, its #81 holding.
  • Maryland Capital Management first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 31 quarters since.
  • Maryland Capital Management's iShares Biotechnology ETF position peaked at $2.25M in Q4 2020.
  • 830 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on Maryland Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.